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Purpose. To evaluate outcomes of an endovascular graft incorporating the visceral aortic segment with graft material in the
setting of juxtarenal aneurysms.
Materials and methods. A prospective analysis of patients undergoing implantation of an endovascular device with graft
material proximal to the renal arteries was conducted. All patients were deemed unacceptable candidates for open surgical
repair and had proximal neck length ¼ ,10 mm, or ¼ ,15 mm with a compromising morphology (funnel or thrombus).
Fenestrations were customized to accommodate aortic branch anatomy based upon CT and intravascular ultrasound data.
Selective visceral ostia were treated with balloon expandable stents following endograft deployment. All patients were
evaluated with CT, duplex ultrasound, and abdominal radiograph at discharge, 1, 6, 12 and 24 months.
Results. A total of 32 patients were enrolled in the trial. Short proximal necks (3–10 mm) were present in 22, and 10 had
necks 10–15 mm in length with concomitant angulation or thrombus compromising neck quality. Endograft design
included bifurcated (30) and aortic tube (2) systems. A total of 83 visceral vessels were incorporated (mean of 2.6 per
patient). These most commonly included both renal arteries and the SMA. All prostheses were implanted successfully
without the acute loss of any visceral arteries. The mean follow-up was 9.2 months (range 0–24 months). One patient died
within 30 days of device implantation and hypogastric bypass following the development of aspiration pneumonia. Three
early (,30 days) and three late secondary interventions were performed. The 30-day endoleak rate was 6.5%. The aneurysm
sac decreased greater than 5 mm in 58% of patients at 6 months and in 75% of patients at 12 months. One patient, with a
persistent type II endoleak had 5 mm of sac growth over 12 months. Six patients had transient or permanent elevation of
serum creatinine (.30% from baseline), with one requiring hemodialysis. Of the 83 vessels incorporated, three late stenoses
(all successfully treated with an endovascular approach) and two renal occlusions were detected during follow-up. Three
patients died of unrelated causes during the follow-up period.
Conclusions. The placement of endovascular prostheses with graft material incorporating the visceral arteries is technically
feasible. The incidence of endoleaks is exceptionally low. It remains critical to follow the status of stented visceral vessels, and
establish the long-term efficacy of this type of repair.
Key Words: Aortic aneurysm; Endovascular aneurysm repair; Juxtarenal aneurysm; Pararenal aneurysm; Stentgraft; Renal
stent; Fenestrated endografts.
Introduction
Patients presenting with abdominal aortic aneurysms
(AAA) are treated with endovascular prosthesis based
upon selected anatomical criteria. They include prox-
imal neck diameter, length, angulation and shape.1,2
Compromised proximal neck anatomy is the most
frequent rejection criteria for treatment with an
endovascular prosthesis. Although more robust prox-
imal fixation systems, such as those with barbs or
uncovered suprarenal stents may provide improved
device stability, the need for a sealing zone above the
aneurysm must be viewed separately. Maximizing the
sealing zone with conventional prosthesis requires
accurate delivery of the graft material to the immedi-
ate infrarenal location. Furthermore, angulation,
abnormal morphology (such as thrombus or neck
irregularities) may limit the success. These reasons
have provided an impetus for the development of
devices with extended sealing zones.
The first reports of fenestrated devices were
published in 1999,3 and followed by the development
of a modular system by John Anderson and Michael
Lawrence-Brown. Anderson and Stanley, reported
their initial experiences in a combined total of 16
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patients, without acute vessel loss or death.4,5
Additional case-reports with various designs have
been published6 as well as a subset of patients
included in this series.10 It is the intent of this
publication to describe the technical aspects and
results using fenestrated endovascular devices in
patients with compromised proximal neck anatomy.
Materials and Methods
Patients were prospectively enrolled in a physician
initiated (not industry sponsored) investigational
device exemption protocol beginning in August 2001.
The results were analyzed through December 2003. All
patients were deemed physiologically high-risk (such
as evidence of non-reconstructable cardiac ischemia,
ejection fraction ,25%, significant chronic obstructive
pulmonary disease or chronic renal insufficiency) for
open surgical repair, and anatomically unsuitable for
traditional infrarenal endovascular grafts. Patients
were selected for treatment if the aneurysms were
greater than 5.5 cm, grew more than 0.5 cm over 1 year,
or were otherwise felt to be at high risk for rupture
(morphology, relative diameter with respect to native
vasculature). Informed consent, approved by the
Institutional Review Board, was obtained for all
research subjects.
The preoperative assessment of the aortic mor-
phology centered on high-resolution helical CT-scans
incorporating the distal descending thoracic aorta
through the profunda femoris. Arteriography was
utilized selectively to evaluate concomitant occlusive
disease of the visceral or pelvic vasculature. The
Zenith device (Cook Inc., Bloomington, Indiana)
formed the foundation of the fenestrated graft. The
material construct and delivery system are similar to
the Zenithe described elsewhere.7 Critical differences
include a proximal portion of the device that is
customized to match the patient specific orientation
of the visceral vessels. Most commonly this involved a
proximal tubular component design that was coupled
with a separate bifurcate system. The addition of one
or two limb extensions completed the implant. Device
design required accurate information regarding the
ostial diameter of each visceral vessel, their relative
distances from a fixed landmark (the superior mesen-
teric artery), and the orientation from which they arise
from an aortic cross-section. Fenestrations were con-
structed to match the ostial diameter and maximize
the sealing zone. Small fenestrations had a diameter
between 6 and 8 mm, and were located at a minimum
of 15 mm distal to the top of the fabric. The ostia for the
small fenestrations were placed between stent struts of
the aortic device, to allow unimpeded access into the
visceral artery, and intended to be used in conjunction
with a balloon expandable stent within the target
vessel. Large fenestrations had greater diameters with
a strut crossing the fenestration, and thus not intended
for use with additional stents. Scallop fenestrations
were hemiovals 6–10 mm in height and an 8–12 mm
diameter located at the most proximal portion of the
fabric. Diagram 1 illustrates the design options for the
fenestrated segment.
Procedure
Bilateral femoral artery exposure was achieved after
the induction of anesthesia (epidural anesthesia in 28
cases, and general anesthesia in four cases). Patients
were anticoagulated with heparin such that activated
clotting times were maintained greater than 300 s. A
stiff wire was placed into the ascending aorta through
the side chosen to delivery the main body, while a
double puncture was performed in the contralateral
femoral vessel to allow the placement of two 8F
sheaths. A multi sidehole flush catheter was placed
through one of the sheaths to visualize the renal
arteries intermittently using small bursts (5–7 cc at
30 cc/s) of non-ionic contrast. The proximal tubular
fenestrated endograft component was oriented using
gold markers located on the device body and around
each fenestration. Partial deployment of this com-
ponent was followed by minute rotational adjustments
to properly orient the fenestrations with their respect-
ive ostia (Fig. 1). Access to main body was achieved
from both access ports within the contralateral femoral
using selective catheterization techniques. Renal
artery access was established in a similar manner,
Diagram 1. This illustration depicts the variety of fenestra-
tion options. Image 1 shows a small fenestration without
struts crossing the orifice. Image 2 shows a large fenestration
with at least one strut that crosses the opening, potentially
making it difficult to use in conjunction with an additional
stent. Image 3 demonstrates a scallop fenestration, located at
the proximal aspect of the fabric, not typically used in
conjunction with additional stents.
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and established prior to release of a tethering wire
that provided a means to achieve partial diameter
expansion of the fenestrated component, allowing
improved rotational ability. The top cap of the device
was released following the placement of guiding
catheters into the renal arteries. A balloon expandable
stent was chosen that was a minimum of 17 mm in
length and deployed on a 7 mm £ 2 cm balloon such
that 2/3 of the stent was within the visceral vessel, and
1/3 extended into the aorta (Fig. 2). The aortic portion
of the stent was then flared with a 10 mm balloon and
subsequently with a compliant latex balloon. The
second (bifurcated) component was implanted allow-
ing at least two stents of overlap. The remainder of the
deployment did not differ from previously described
publications, and details are available in the device
instructions for use.5
Patient follow-up
Postoperative evaluations were conducted at hospital
discharge, 1, 6, 12 and 24 months. Helical CT scans,
duplex ultrasound (with the exception of the dis-
charge timepoint), creatinine assessment, and flat plate
radiography were obtained. Secondary interventions
were performed in the setting of a suspected type 1 or
3 endoleak, compromised visceral vessel flow, or
aneurysmal growth. When appropriate, outcome
analyses were conducted in accordance with the
reporting standards for endovascular aneurysm
repair.8 Elevation of serum creatinine was considered
significant if the baseline level increased to greater
than 2 mg/dl or a rise of .30% from baseline was
noted. Duplex end systolic and diastolic velocities
were depicted in each visceral and renal arteries and
aortic ratios calculated at each follow-up and com-
pared to baseline.
Results
A total of 32 patients were treated. There were 29 men
and three women with a mean age of 76 ^ 9 years. The
pre-operative risk factors are listed in Table 1. The
majority of patients had isolated abdominal aortic
aneurysms, however, three patients had associated
iliac aneurysms, and two patients had thoracic
aneurysms. The mean diameter of the proximal neck
was 27 ^ 4 mm (range 21–32 mm). The proximal neck
length was ,10 mm in 24 patients, and between 10
and 16 mm in eight patients, all of which had
morphologic factors implying compromised sealing
or fixation. These included moderate angulation
(.408, ,608) of the proximal neck in 11 patients, and
severe angulation (.608) in seven patients. The
presence of thrombus or calcification incorporating
2/3 or more of the proximal neck circumference was
noted in 16 patients and 13 patients, respectively. The
shape of the pararenal aorta was considered to have an
inverted funnel ðn ¼ 9Þ; funnel ðn ¼ 9Þ; irregular ðn ¼
6Þ; or parallel ðn ¼ 8Þ shape. Mean maximum trans-
verse diameter (MTD) and maximum anteroposterior
diameter (MAPD) of the AAA were 63 ^ 13 mm
Fig. 1. Small bursts of non-ionic contrast (5–7 cc at 30 cc/s)
are injected to properly visualize the renal ostia through a
multiside hole flush catheter. This allows meticulous place-
ment (longitudinal and rotations) of the proximal aspect of
the device. The four gold markers depicting the right renal
fenestration are shown in this image.
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(range 45–100 mm) and 58 ^ 12 mm (range 44–
90 mm), respectively.
A total of 83 visceral vessels (Fig. 3) were
incorporated in the prosthesis design (with a mean
of 2.6 per patient). The fenestration was a ‘small’
fenestration in 53 cases, and a ‘scallop’ in 30 cases.
Table 2 demonstrates the distribution of renal,
superior mesenteric and celiac arteries treated. There
was one acute visceral vessel (renal) loss (in addition
to a single accessory renal that was intentionally
covered).
Procedure
All prostheses were implanted at the intended site. A
conduit to the common iliac artery (10 mm diameter
Polyester vascular graft) was planned and performed
in two patients. The single vessel that was not
successfully catheterized and ultimately thrombosed
was located in a tortuous portion of a short proximal
neck. Procedural time averaged 214 ^ 65 min with a
Table 1. Preoperative co-morbidities or risk factors for the 32
patient cohort
Patients ðnÞ %
Arterial hypertension 20 63
Diabetes 3 1
Coronary artery disease 20 63
Renal insufficiency (creatinaemia .120 mmol/l) 5 16
COPD 21 66
Previous laparotomy 4 13
Obesity (weight .110% ideal body weight) 7 22
Previous stroke 8 25
Table 2. This table depicts the distribution of vessels incorporated
into the fenestrated devices used in this series
Mesenteric fenestrations Number of renal fenestrations
1 2 3
None 3 9 0
SMA 0 18 1
SMA þ CELIAC 0 1 0
The vast majority of patients had devices involving two main renal
arteries and the SMA. A single patient had a large accessory renal
that was preserved with a third renal fenestration, and two patients
had renal arteries that were markedly disparate, requiring only
single fenestrations. Only one patient required incorporation of all
four visceral vessels.
Fig. 2. This image depicts the placement of a balloon-
expandable stent into the left renal artery. Following the
placement of this stent on a 7 mm £ 2 cm balloon, the aortic
portion (that is extending about 5 mm into the aorta) is flared
with a 10 mm £ 2 cm balloon. A compliant latex balloon is
then used to complete the flare.
Fig. 3. This completion angiogram demonstrates patency of
the three vessels incorporated in this fenestrated endograft
(two small fenestrations for the renal arteries and one scallop
fenestration for the superior mesenteric artery). The black
arrow depicts the SMA.
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mean of 56 ^ 23 min of fluoroscopy time. The mean
volume of contrast utilized was 170 ^ 42 ml.
The use of a large balloon expandable stent
immediately below the renal arteries was required in
four patients, and at the level of the main body joint in
one patient (Fig. 4). Additional self-expanding stents
were implanted into 7 iliac limbs to alleviate kinking
or unacceptable tortuosity following endograft
deployment. Extensions were required in two patients
to achieve optimal device overlap. One patient
Fig. 4. A joint type three endoleak is depicted on the early post-operative CT-scan (a) and found angiographically to have
originated from the modular joint between the fenestrated tubular component and the main body bifurcation (b). After
implantation of a complementary balloon-expandable stent (arrow) the leak has resolved (c).
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required a femoral endarterectomy and prosthetic
patch closure on the side of the main delivery system
insertion.
Early follow-up (,30 days)
One patient (3%) died 7 days after the initial
procedure. This patient had bilateral common iliac
aneurysms and an attempted hypogastric bypass
which was aborted due to difficult pelvic access
(patient weight was 253 lbs.). Although, the patient
initially did well, however, he developed an ileus and
aspiration pneumonia, further compromising his
chronic obstructive pulmonary disease. He ultimately
died of multisystem organ failure. The immediate
post-procedural CT depicted a type II endoleak in
eight patients, of which only two were present at 30
days. One proximal type I endoleak, and a single type
III (at a modular joint) endoleak were noted and
treated within 30 days of the initial procedure.
Late follow-up (.30 days)
The mean follow-up was 9.2 months (range 0–24
months), without any patients lost to follow-up. Three
patients expired during the follow-up period, at 2, 6
and 6 months. One death resulted from a hemorrhagic
duodenal ulcer resistant to endoscopic cauterization
(non-surgical candidate), another expired from severe
coronary insufficiency, and the third died of a remotely
ruptured aneurysm (aortic arch). Two patients with-
drew from the study at the 12-month follow up time
point.
The 30-day endoleak rate was 6.5% (two type II
endoleaks). Sac shrinkage (.5 mm) was present in
58% (15/26) of patients at six months and in 76%
(19/25) at twelve months. Only one patient demon-
strated aneurysmal growth of 5 mm, in the setting of a
persistent type II endoleak, who has refused further
intervention at this time.
Renal function
Six patients (18.8%) developed an increase in serum
creatinine (.30% over baseline) following treatment.
Two patients had a transient rise that later returned to
normal levels by the 6-month measurement, attributed
to either atheroemboli or contrast nephropathy. All
four of the remaining patients with elevated serum
creatinine had evidence of renal arterial pathology
including three renal occlusions (one accessory renal
intentionally covered, one renal artery thrombosis
following prolonged hypotension after a ruptured
thoracic aneurysm, and one patient with a renal
occlusion noted at the 12 month duplex study), and
one renal stenosis which was percutaneously treated.
Visceral vessel patency
In addition to the aforementioned renal artery issues a
single patient, at 12 months, was diagnosed with a
renal artery stenosis by duplex ultrasound (without
elevation of creatinine or blood pressure), and treated
percutaneously. Additionally, one patient was noted to
have an SMA stenosis within 30 days of the procedure,
which was detected with duplex, but not visualized
angiographically. However, an intravascular ultra-
sound evaluation demonstrated fabric material par-
tially obstructing the SMA origin, which was treated
successfully with a self-expanding stent. Overall,
impaired blood flow was detected in six of the 83
vessels incorporated within the fenestrated pros-
theses; successful treatment was undertaken in three
patients presenting with stenoses, and no treatment in
the other three patients presenting with occluded
vessels.
Lower extremity perfusion
No patients developed worsening of the measured
ankle–brachial indices during the follow-up period.
However, a single patient with a baseline ABI of 0.67
suffered an embolic event to her great toe. A
superficial femoral artery angioplasty was performed
to improve the potential for healing this lesion. She
later required repeat angioplasty of the SFA and
external iliac artery and underwent a great toe
amputation.
Discussion
Fenestrated endovascular grafts were designed to
extend the proximal sealing zone, accommodate
native arterial angulation, and potentially improve
proximal fixation. The fenestrations were intended to
incorporate any visceral vessels that encroached on the
desired sealing zone. Although conceptually a hole
placed within the fabric may preclude a seal, the effect
of flaring the aortic portion of the renal stent served to
rivet the fabric of the prosthesis against the aortic wall,
or slightly within the renal artery. Despite this ability, a
segment of proximal neck is required and the treatment
of true suprarenal aneurysms with an endovascular
approach is relegated to branch vessel techniques.9
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Successful results with a fenestrated graft required
appropriate patient selection, proper device design,
and technical expertise with endovascular grafting as
well as visceral vessel cannulation and stenting. The
absence of any one of these factors will result in
visceral vessel loss, unprotected aneurysms, or the
need for conversion. For this reason, it is imperative
that high-resolution imaging studies be obtained and
carefully evaluated for acceptability. Complicating
anatomic factors include visceral vessel stenoses,
iliac tortuosity or calcifications that diminish the
rotational freedom of the device, and proximal neck
angulation. In addition to conventional endovascular
device sizing requirements, fenestrated device design
requires accurate distance calculations to be made
between each of the visceral vessels. Furthermore, the
location of the visceral vessel ostia from the aortic
circumference is important. With these data, one can
design a prosthesis that will incorporate the required
vessels. Design is limited by the need for unimpeded
access through small fenestrations, such that they are
created at least 15 mm below the proximal fabric
margin. This restriction ensures that the fenestration
diameter does not incorporate a strut from the aortic
prosthesis and can thus be relatively easily protected
with a stent. Disparate renal arteries, or short distances
between the renal arteries and superior mesenteric
artery were accommodated with either multiple
fenestrations or the use of a scallop. Regardless of a
given design, multiple alternatives could be con-
structed and it was ultimately the preference of the
treating physician as to the proximal extent of cover-
age and degree of visceral vessel incorporation.
Despite a proper design, the implantation pro-
cedure can be challenging. The delivery system is a
modification of the traditional Zenith system.7 A third
trigger wire is used as a tether to allow partial
expansion of the fenestrated portion within the
proximal neck following sheath retraction. Thus,
access to the internal portion of the graft and
subsequently the desired visceral vessels, is estab-
lished while maintaining the ability to rotate and
advance the device. However, neck angulation, and
tortuous calcific iliac arteries limit this. Furthermore
extensive manipulation of the device within the
aneurysm and proximal neck has the potential to
increase the risk of distal embolization, as was noted in
one patient in this study.
The protection of the renal ostia with stents has
been the subject of some controversy. Two types of
stents were utilized during the course of the study.
These included 0.03500 and 0.01400 systems. The larger
system was used in the absence of renal disease
(stenosis) and in the setting of single renal arteries,
while the presence of significant occlusive disease or
the need for kissing stents due to multiple renal ostia
in close proximity, or early main renal artery bifur-
cations, prompted the use of the coronary systems. The
0.03500 system incorporated the use of a 17 mm long
EV3 double strut balloon-expandable stent (EV3,
Plymouth, MN) deployed through an 8F MPB guiding
catheter (Cook Inc). The initial deployment of this
stent was based upon the diameter of the fenestration
rather than renal artery diameter (unless the renal was
smaller than the fenestration). This stent was associ-
ated with favorable flaring properties. In contrast, a
lower profile stent (Herculink, Guidant Inc, Menlo
Park, California) was used for more complicated
renals. This stent was not flared beyond the desired
renal/fenestration diameter. Although, the absence of
a flare would likely make later renal access more
challenging, the profile of the delivery system, in
conjunction with formed 6F guiding catheters and
overall stent performance made more palatable.
Despite the technical features allowing the more
proximal placement of graft material in the visceral
aortic segment, a small number of proximal endoleaks
were still noted. This was found to be especially
prevalent in the setting of neck angulation. These leaks
were all treated during the initial implantation with
the superimposition of a Palmaz stent (Cordis Inc.,
Great Lakes, NJ). This stent was deployed below the
renal artery stents and provided additional radial
force in that region. It furthermore had the effect of
straightening any angulation in that region. However,
it is important to note that the preclinical testing for
this prosthesis did not incorporate the use of such a
stent. The overall low incidence of endoleak, particu-
larly type I leaks, supports the concept that the
extended sealing zone adequately excludes the aneur-
ysm, even in the setting of very short proximal necks.
This is further reinforced by the sac shrinkage,
although with multiple modular components, an
emphasis must be placed on ensuring adequate
overlap continues to exist between the segments of
the device. In the absence of aneurysm exclusion,
shrinkage would not likely occur. The fact that it was
noted in the majority of our patients at the 6 month
follow-up visit gives us optimism that the natural
history of the aortic disease has been reversed with the
use of this device.
Our results demonstrated that experienced endo-
vascular teams can safely treat patients with challen-
ging neck anatomy. Early post-operative mortality was
low, secondary interventions were relatively infre-
quent, and sac shrinkage was common. Worsening
renal function was uncommon, but the presence of
restenosis in a single patient was significant and
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demonstrates the importance of duplex follow-up to
determine sub-clinical stenoses. Despite these
encouraging early results, longer-term data and
additional patients will be necessary to determine
the safety and efficacy of such a device.
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